Efficacy of Lagopsis supina to promote blood circulation, remove blood stasis, and block inflammation in a rat model of traumatic blood stasis

• Published in: Brazilian Journal of Pharmaceutical Sciences Vol. 58
• Main Authors: Xu, Tingting, Wang, Xiumei, He, Zhongwei, Yang, Li, Wei, Rongrui, Zhong, Guoyue, He, Junwei
• Format: Journal Article
• Language: English
• Published: Universidade de São Paulo, Faculdade de Ciências Farmacêuticas 2022; Universidade de São Paulo
• Subjects: Anti-inflammatory; Lagopsis supina; PHARMACOLOGY & PHARMACY; Promoting blood circulation and removing blood stasis (PBCRBS); Traumatic blood stasis (TBS); Traumatic blood stasis (TBS); Promoting blood circulation and removing blood stasis (PBCRBS); Lagopsis supina; Anti-inflammatory
• ISSN: 2175-9790; 2175-9790
• DOI: 10.1590/s2175-97902021000x32e19359

Abstract Lagopsis supina (Steph) IK. Gal. was a traditional Chinese medicinal plant for promoting blood circulation and removing blood stasis (PBCRBS), anti-inflammatory and diuresis with little scientific validation. The aims of this study were first to evaluate the PBCRBS and anti-inflammatory effects of L. supina in a rat model of traumatic blood stasis (TBS). We demonstrated that an ethanolic extract of L. supina (LS, 460 mg/kg/d) possessed significant PBCRBS and remarkable inhibitory effect on inflammation cytokines, which were associated with renovated amount of the injured muscle fibers, alleviate the degree of the damaged tissue edema, decreased the number of inflammatory cells, increased the number of the capillary hyperplasia by hematoxylin and eosin (HE), as well as remarkably down-regulated ( p < 0.05 or p < 0.01) the levels of inflammation cytokines, including TNF-α, IL-6, IL-8, and IL-10 by ELISA. This finding provide a pharmacological basis and partial interpretation for the clinical application of L. supina, which has therapeutic properties for blood stasis syndrome (BSS) and inflammation-related diseases.